H.R. 2297 · 118th Congress
To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024.
- Stage
- In committee
- Sponsor
- Andy Biggs
- Introduced
- 2023-03-29
- Latest action
- 2023-04-07 · Referred to the Subcommittee on Health.